Anixa Biosciences Inc (ANIX)
2.49
+0.08
(+3.11%)
USD |
NASDAQ |
May 28, 16:00
2.48
-0.01
(-0.40%)
After-Hours: 20:00
Anixa Biosciences Price: 2.49 for May 28, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 28, 2024 | 2.41 | 2.50 | 2.41 | 2.49 | 56278.00 |
May 24, 2024 | 2.63 | 2.637 | 2.40 | 2.415 | 219907.0 |
May 23, 2024 | 2.60 | 2.78 | 2.50 | 2.66 | 172517.0 |
May 22, 2024 | 2.70 | 2.77 | 2.60 | 2.60 | 96067.00 |
May 21, 2024 | 2.80 | 2.850 | 2.70 | 2.73 | 113064.0 |
May 20, 2024 | 2.94 | 2.94 | 2.80 | 2.84 | 74881.00 |
May 17, 2024 | 2.92 | 2.92 | 2.83 | 2.85 | 73975.00 |
May 16, 2024 | 2.89 | 3.01 | 2.89 | 2.91 | 30047.00 |
May 15, 2024 | 3.00 | 3.04 | 2.90 | 2.93 | 51033.00 |
May 14, 2024 | 2.96 | 3.025 | 2.95 | 2.98 | 35008.00 |
May 13, 2024 | 2.99 | 3.04 | 2.95 | 2.97 | 37757.00 |
May 10, 2024 | 2.89 | 3.04 | 2.89 | 3.00 | 117116.0 |
May 09, 2024 | 3.02 | 3.07 | 2.85 | 2.87 | 92160.00 |
May 08, 2024 | 3.01 | 3.05 | 2.940 | 3.02 | 61570.00 |
May 07, 2024 | 2.99 | 3.02 | 2.86 | 2.91 | 61801.00 |
May 06, 2024 | 2.97 | 3.05 | 2.96 | 3.02 | 67858.00 |
May 03, 2024 | 3.01 | 3.06 | 2.85 | 2.94 | 115775.0 |
May 02, 2024 | 3.09 | 3.101 | 2.97 | 2.97 | 52136.00 |
May 01, 2024 | 2.98 | 3.15 | 2.98 | 3.09 | 58633.00 |
Apr 30, 2024 | 3.03 | 3.086 | 2.915 | 2.97 | 117723.0 |
Apr 29, 2024 | 3.22 | 3.25 | 3.02 | 3.02 | 158338.0 |
Apr 26, 2024 | 3.15 | 3.319 | 3.13 | 3.23 | 237328.0 |
Apr 25, 2024 | 3.25 | 3.32 | 2.94 | 2.98 | 251933.0 |
Apr 24, 2024 | 3.22 | 3.400 | 3.04 | 3.18 | 357353.0 |
Apr 23, 2024 | 3.03 | 3.12 | 3.00 | 3.07 | 73542.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.35
Minimum
Mar 27 2020
7.14
Maximum
Mar 17 2021
3.645
Average
3.65
Median
Jul 08 2019
Price Benchmarks
CEL-SCI Corp | 1.27 |
AIM ImmunoTech Inc | 0.35 |
IGC Pharma Inc | 0.50 |
NovaBay Pharmaceuticals Inc | 0.141 |
Protalix BioTherapeutics Inc | 1.16 |
Price Related Metrics
Price to Book Value | 3.215 |
Earnings Yield | -13.71% |
Market Cap | 79.11M |